VR Adviser, LLC Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$1.6T
Holdings
35
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (35 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APGEAPOGEE THERAPEUTICS INC | 8,493,321 | $334.2B | 21.28% | |
| 2 | ELVNENLIVEN THERAPEUTICS INC | 4,026,331 | $94.1B | 5.99% | |
| 3 | FDMT4D MOLECULAR THERAPEUTICS IN | 4,400,000 | $92.4B | 5.88% | |
| 4 | OCULOCULAR THERAPEUTIX INC | 12,762,462 | $87.3B | 5.56% | |
| 5 | DYNDYNE THERAPEUTICS INC | 2,173,913 | $76.7B | 4.89% | |
| 6 | MRUSMERUS N V | 1,263,214 | $74.7B | 4.76% | |
| 7 | KALVKALVISTA PHARMACEUTICALS INC | 6,249,731 | $73.6B | 4.69% | |
| 8 | PHVSPHARVARIS N V | 3,395,606 | $63.8B | 4.07% | |
| 9 | SYRESPYRE THERAPEUTICS INC | 2,685,448 | $63.1B | 4.02% | |
| 10 | DNTHDIANTHUS THERAPEUTICS INC | 2,094,373 | $54.2B | 3.45% | |
| 11 | VRDNVIRIDIAN THERAPEUTICS INC | 3,882,671 | $50.5B | 3.22% | |
| 12 | COGTCOGENT BIOSCIENCES INC | 5,684,167 | $47.9B | 3.05% | |
| 13 | APLTAPPLIED THERAPEUTICS INC | 9,542,871 | $44.6B | 2.84% | |
| 14 | ERASERASCA INC | 16,216,216 | $38.3B | 2.44% | |
| 15 | CATBUSDASTRIA THERAPEUTICS INC | 3,608,645 | $32.8B | 2.09% | |
| 16 | EWTXEDGEWISE THERAPEUTICS INC | 1,818,182 | $32.7B | 2.09% | |
| 17 | ORICORIC PHARMACEUTICALS INC | 4,394,527 | $31.1B | 1.98% | |
| 18 | PRAXPRAXIS PRECISION MEDICINES I | 706,131 | $29.2B | 1.86% | |
| 19 | ENGNENGENE HOLDINGS INC | 2,825,983 | $26.6B | 1.70% | |
| 20 | CGEMCULLINAN THERAPEUTICS INC | 1,379,965 | $24.1B | 1.53% | |
| 21 | TERNTERNS PHARMACEUTICALS INC | 3,410,058 | $23.2B | 1.48% | |
| 22 | —MERSANA THERAPEUTICS INC | 11,328,000 | $22.8B | 1.45% | |
| 23 | ZURAZURA BIO LTD | 6,023,166 | $21.1B | 1.34% | |
| 24 | TSHATAYSHA GENE THERAPIES INC | 9,000,000 | $20.2B | 1.28% | |
| 25 | ABVXABIVAX SA | 1,345,780 | $17.8B | 1.13% | |
| 26 | ARVNARVINAS INC | 627,788 | $16.7B | 1.06% | |
| 27 | AQSTAQUESTIVE THERAPEUTICS INC | 5,555,555 | $14.4B | 0.92% | |
| 28 | IPSCCENTURY THERAPEUTICS INC | 5,389,259 | $13.7B | 0.88% | |
| 29 | CABACABALETTA BIO INC | 1,563,952 | $11.7B | 0.75% | |
| 30 | TRVITREVI THERAPEUTICS INC | 3,422,637 | $10.2B | 0.65% | |
| 31 | AVU0ADVERUM BIOTECHNOLOGIES INC | 1,467,048 | $10.1B | 0.64% | |
| 32 | —PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.5B | 0.48% | |
| 33 | TNYATENAYA THERAPEUTICS INC | 1,555,556 | $4.8B | 0.31% | |
| 34 | ABIOEURARCA BIOPHARMA INC | 866,375 | $3.3B | 0.21% | |
| 35 | —CASI PHARMACEUTICALS INC | 111,686 | $614.3M | 0.04% |